Randomized And Multicentric Phase III Study Evaluating The Benefit By Using A Chemotherapy With FEC 100 And Docetaxel In Non Metastatic Breast Cancer Which Has Relapsed After A Conservative Surgery.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Anastrozole; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil; Goserelin; Tamoxifen
- Indications Breast cancer
- Focus Therapeutic Use
- 16 Dec 2014 Biomarkers information updated
- 08 Nov 2010 Investigational drug identified as anastrozole, goserelin and tamoxifen as reported by ClinicalTrials.gov.
- 13 Sep 2005 New trial record.